Background: Animal studies and human case reports show promise of lipid rescue for refractory calcium channel antagonist (CCA) toxicity. However, lipid therapy has not been studied for nifedipine, a dihydropyridine CCA. Hypothesis: Lipid rescue will restore circulation following severe nifedipine intoxication in a swine model. Methods: This IACUC-approved pilot study utilized five swine that were sedated with alpha-chloralose, mechanically ventilated, and instrumented for drug delivery and hemodynamic measures. After stabilization and basal measures, nifedipine (0.0175 mg/kg/ min) was infused until imminent cardiac arrest (seizure, end tidal CO 2 <10 mmHg or bradydysrhythmia). Animals then received a 17 ml/kg 20 % lipid bolus via central catheter. Lipid circulation was visually confirmed by the presence of fat in peripheral arterial blood. Hemodynamics were continuously monitored until 10 min after lipid bolus. Surviving animals were euthanized. Preand post-lipid treatment parameters were analyzed using unpaired t test (p<0.05 significant). Results: Nifedipine toxicity was characterized by vasodilatory hypotension, impaired contractility, and tachycardia with terminal bradycardia (see table) . The mean time to imminent cardiac arrest from start of nifedipine infusion was 232±77 min. Lipid treatment did not improve or restore circulation in any animal. Discussion: There was no benefit from lipid rescue in this model of nifedipine toxicity. Limitations to the results include potential excessive toxicity, inadequate lipid dose, insufficient observation time for treatment effect, or a direct adverse effect of lipid. Further study of earlier treatment or different lipid doses is warranted.
Pretreatment with Intravenous Lipid Emulsion Reduces Mortality from Cocaine Toxicity in a Rat Model
Carreiro S, Blum J, Hack JB Brown University, Providence, RI, USA Background: Intravenous lipid emulsion (ILE) is efficacious in the treatment of severe toxicity from local anesthetics and as well as other lipophilic drugs. Given that cocaine has a lipid partition coefficient of 2.3, its toxicity may be helped by ILE administration.
Purpose: The purpose of this study was to determine ILE's effect on cocaine-induced mean arterial pressure (MAP) changes and mortality in a rat model compared with control.
Methods: This is an experimental animal model of cocaine toxicity using male Sprague Dawley rats. Twenty subjects were sedated, ten animals received ILE and ten received normal saline (NS) in the same 15 ml/kg dose, this was followed by a 10 mg/kg bolus of intravenous cocaine. Continuous hemodynamic monitoring included intra-arterial blood pressure, heart rate and electrocardiogram tracing. End points included a sustained undetectable MAP or return to baseline for 5 min. Two tailed T tests were used to compare the groups on a number of hemodynamic parameters.
Results: Seven of ten NS animals died and 3/10 ILE animals died. Odds ratio for mortality in NS vs ILE group was 9.33 (95 % CI 1.1934-72.99, p00.033). Between groups, there were no differences in baseline MAP, maximum MAP reached, or time to maximum/minimum MAP after cocaine exposure. The NS group reached a significantly lower MAP than the ILE group after cocaine exposure (p00.001). Discussion: ILE blunted hypotensive effects and decreased cocaineinduced death compared with NS in this rat model. Given that there is no antidote for severe cocaine toxicity and ILE is a relatively inexpensive and safe treatment, this would represent a significant improvement in our current therapy for this exposure, which is supportive care only. Our small sample size limits the interpretation of mortality data. Conclusions: ILE should be investigated further as a potentially lifesaving adjunct in the treatment of severe cocaine toxicity in humans. Background: Copperhead snake (Agkistrodon contortrix) envenomation produces predominantly local tissue effects in the envenomated limb. No published studies have measured recovery from these envenomations.
Research questions: How do the signs, symptoms, and functional status of patients envenomated by copperhead snakes vary over time? What patient-and clinician-reported outcome measures are responsive and useful to study this population? Methods: This is a multicenter prospective observational study of non-pregnant adults envenomated on a limb, distal to the elbow or knee, by a copperhead snake. Patients were enrolled regardless of antivenom administration. Assessments were made 3, 7, 14, 21, and 28 days after envenomation using the Disorders of the Arm, Shoulder and Hand (DASH), Lower Extremity Functional Score (LEFS), Patient-Specific Functional Scale (PSFS), Work Productivity and Activity Index: Special Health Problem (WPAI:SHP), Patient Global Impression of Change (PGIC), Patient Global Assessment of Recovery (PGAR), and SF-36 (acute) instruments. Grip strength, 7.62-m walking speed, and swelling (figure-of-eight) were measured. Analgesic use and return to work were assessed. Pain was assessed using an 11-item Likert scale. Results: Data from 16 patients, including 13 treated with antivenom, were available for this preliminary analysis. Measures of pain, analgesic use, swelling, and functional impairment all showed marked abnormalities 3 and 7 days after envenomation. Most subjects had little or no residual abnormality by the 28-day assessment. The degree of abnormality measured at 14 and 21 days post-envenomation differed by the health outcome assessed. Percent change over time was greatest for the DASH, WPAI:SHP, and PSFS instruments and grip strength measurement. Discussion: The small number of patients managed without antivenom in these preliminary data did not provide sufficient power to detect treatment effect. Conclusion: In this preliminary analysis in which most patients received antivenom, victims of copperhead snakebite suffer pain, swelling, and functional impairment lasting 7-28 days.
Diethylene Glycol Metabolites Are Associated with Diethylene Glycol Poisoning in Humans
Schier JG Hypothesis: The DEG metabolites hydroxyethoxyacetic acid (HEAA) and diglycolic acid (DGA) are associated with DEG poisoning. Methods: Samples with sufficient volumes of serum, urine and cerebrospinal fluid (CSF) were analyzed by GC/MS for DEG, hydroxyethoxyacetic acid (HEAA), diglycolic acid (DGA), ethylene glycol (EG), glycolic acid (GA), and oxalic acid (OA). Median and range were calculated. The Wilcoxon rank sum test (exact p values) and bivariable exact logistic regression were used in SAS v9.2 to analyze serum/urine data. Results: Twenty case and 20 control serum samples, 11 case and 22 control urine samples, 9 case CSF samples and 1 CSF sample from a bio-bank used as a blank were analyzed. Descriptive data is presented in the table. Regression analyses demonstrated associations between case status and: (1) serum OA and serum HEAA (both OR014.6, 95 % CI02.8-100.9), (2) serum DGA and urine DGA (both OR>999, exact p<0.0001), and (3) urinary GA (OR0 0.057, 95 % CI00.001-0.55). Discussion: DEG metabolism yielded significantly elevated HEAA (serum) and DGA (serum and urine) concentrations among cases. As urinary GA elimination decreased from AKI in cases, serum GA likely increased, which was then converted to serum OA. Analytical methods need further validation. Conclusion: Serum DGA, urine DGA, and serum HEAA concentrations are associated with human DEG poisoning and may be valid biomarkers of DEG-associated illness.
Borderline and Long QT Interval with Medications Associated with QT Prolongation in Adolescent Athletes
Hoyte CO 1 , Coel R Background: Medication errors are the most common form of medical error. "Trigger tools" have been identified as effective methods for identifying medication errors. Research question: This study compared the naloxone trigger to a voluntary reporting system for identifying opioid-related adverse events in the Emergency Department. The characteristics of patients identified by the naloxone trigger are described. Methods: We targeted patients who received opioids in the ED prior to naloxone. Data were extracted from an electronic database regarding demographics, medications and outcomes. A chart review was conducted for patient symptoms, and each case was assigned an NCC-MERP category of harm. This study received IRB approval. Results: From October 2009 to December 2011, 354,784 adult patients were treated in two university-affiliated urban emergency departments. During this period, 1,213 doses of naloxone were administered, with 63 patients receiving naloxone after opioids in the ED. The mean patient age was 57.9 years (SD 21.5). Women and whites accounted for 60.3 and 69.8 % of the population, respectively. Only 7.9 and 12.7 % reported home opioid and home sedative use. The most common indications for naloxone administration were depressed mental status, hypoxia, respiratory depression, hypotension, apnea, and bradycardia (in decreasing order). The NCC-MERP classification is listed in Table 1 . None of the patients in this series were identified by the voluntary error reporting system Discussion: In this study, 19 life-threatening opioid adverse drug events were identified using the naloxone trigger. In contrast, the voluntary medication error/adverse event reporting system failed to capture any of these cases. Conclusions: Overall, iatrogenic opioid-associated adverse events are rare in the emergency department setting. Voluntary reporting systems may fail to identify these adverse events entirely. The naloxone trigger can be used to target opioid-related adverse events, which must be considered a priority by quality improvement/medication safety programs. New York University, New York, NY, USA Background: Errors in prescribing of high-risk medications, such as extended-release or long-acting (ER/LA) opioid formulations, remain an important cause of patient morbidity and mortality. Prescribing errors often relate to the failure to note warnings regarding contraindications and drug interactions. Many physicians utilize electronic pharmacopeia (EP) to improve ordering of ER/LA opioids, which carry a class-wide "black box" warning. Purpose: The purpose of this study was to assess the ability of commonly used apps to provide accurate safety information about the boxed warning for ER/LA opioids. Methods: We evaluated a convenience sample of six popular EP apps available for the iPhone and an online reference for the presence of relevant safety warnings. Two evaluators independently reviewed each program. We accessed the dosing information for each of six ER/LA medications and assessed for the presence of an easily identifiable indication that a boxed warning was present, even if the warning itself was not provided. The level of prominence of precautionary information was classified based on the appearance of a warning: (1) visible in line with dosing information, (2) visible but listed separately, (3) not visible but listed separately, (4) warning not available. Results: Each program provided a consistent level of warning information for each of the six ER/LA medications. Only 2/7 programs placed a warning in line with dosing information (level 1). Three of the seven programs offered level 2 warning. One of the seven offered level 3 warning. One program made no mention of a boxed warning. Agreement on classification by the evaluators was 100 %.
Discussion: Isolation of important safety warnings, perhaps to reduce alert fatigue, may increase the likelihood that a potentially important warning is missed and a dangerous prescription is provided. Conclusion: Most EP apps do not place warnings ahead of or on the same screen as prescribing information and represent a missed opportunity to improve prescribing practices. Results: Five hundred fifty-five subjects with rhabdomyolysis and 240 subjects with APAP overdose were identified. Excluding those with incomplete data resulted in 116 in the rhabdomyolysis group, 40 and 9 in the APAP group (all vs undectable, respectively). AST/ALT ratios in the three groups were 1.56 (IQR, 1.08-2.08), 1.36 (1.12-1.67), and 1.3 (1.24-1.57), respectively. CK/AST ratios in the three groups were 19.24 (9.9-36.8), 5.49 (1.83-15.3), and 3.21 (1.40-4.25) , respectively. CK/ALT ratios in the three groups were 30.96 (11.81-66.7), 7.0 (1.79-25), and 4.1 (1.77-5.5) , respectively. Differences in AST/ALT ratios were not significantly different between the three groups (p00.24). CK/AST ratios were significantly different between the rhabdomyolysis group and the APAP (all) group (p <0.001) and the APAP (undetectable) group (p00.002). CK/ALT ratios were also significantly different between the rhabdomyolysis group and the APAP (all) group (p<0.001) and the APAP (undetectable) group (0.002). Discussion: Both the CK/AST and CK/ALT ratios were significantly larger in patients with rhabdomyolysis. Elevated CK/AST or CK/ALT ratios may aid in the decision-making process when deciding when to treat with NAC when the diagnosis of APAP toxicity is uncertain. Conclusion: CK/AST and CK/ALT ratios are significantly larger in rhabdomyolysis when compared to patients with APAP toxicity. Background: In 1991, Smilkstein et al. reported 179 acetaminophen overdose patients treated using a 48 h IV acetylcysteine protocol. This study was continued but the results of the remaining 133 cases were not reported. The purpose of this report is to describe the overall findings of this study. Methods: This is an IRB-approved, multicenter single-arm openlabeled trial including patients with a toxic concentration who presented within 24 h of an acute acetaminophen overdose. Intervention: The intervention given was an intravenous acetylcysteine of 140 mg/kg loading dose then 12×70 mg/kg q 4 h.
Outcome: Proportion of subjects developed hepatotoxicity (ALT >1,000 u/L). Patients were stratified by time to ingestion (<10 h or >10 h) and by serum concentration (4 h lines starting at 150, 200 and 300 mg/L). Adverse events were recorded. Results: Four hundred eight subjects were enrolled and 312 subjects met criteria for analysis. Most (68 %) were women with a mean (SD) age of 21.8 (10.0) years. The acetaminophen concentration strata were 150-200 mg/L in 60 (19 %), 201-300 mg/L in 94 (30 %), and >300 mg/L in 158 (51 %), 126 (40 %) were treated within 10 h of ingestion. The proportion of subjects who developed hepatotoxicity stratified by time to treatment and initial concentrations is shown in the table. Adverse effects (measured in all 408 treated subjects) occurred in 118 subjects and included vomiting (n038), rash (n030), flushing (n027), nausea (n0 23), pruritus (n016), urticaria (n012), and bronchospasm (n04). Discussion: For patients treated within 10 h, the rate of hepatotoxicity in this study is similar to the rate for patients treated with the 72-h oral protocol (6 %) and slightly higher than the rates reported for the 21-h IV protocol (0 to 4 %). Rates were also similar for those treated >10 h after ingestion (25 vs 26 % oral and 8-53 % IV). Adverse events were uncommon not serious.
Conclusions:
The 48-h acetylcysteine protocol produces results similar to other protocols. Introduction: Medical Toxicology (MT) and Pediatric Emergency Medicine (PEM) were two of the initial ACGME-approved fellowship training programs (FTP) that targeted emergency medicine (EM) graduates. More recently, FTPs in emergency ultrasound (EU), EMS, and critical care/emergency medicine (CC) have been created. The growth of these FTPs has resulted in increased training opportunities for EM residents. Our purpose was to assess the stability of the number of MT programs as these other FTPs expand. Methods: We searched the online database of ACGME for the number of MT fellowship positions from 2001 to 2012. We also searched the SAEM website to determine the number of other fellowship training programs for EM residents many of which have not yet been ACGME approved. 
Telemetry Monitoring in Pediatric Ingestions
Arnold T, Yin S Cincinnati Children's Hospital, Cincinnati, OH, USA Background: Approximately 40,000 patients <19 years old are admitted to hospitals annually because of poisoning. There are no guidelines on which pediatric patients need to have telemetric monitoring. Purpose: The purpose of this study was to examine the number of events captured by telemetry in children and adolescents admitted following an ingestion. Methods: This is a retrospective chart review of patients admitted for ingestion to a telemetry unit of a children's hospital from February 1, 2010 to January 3, 2012. Cases were searched with an admission diagnosis of ingestion, overdose, or poisoning to our single ward with telemetry. Length of stay (LOS) was also recorded.
Results: One hundred sixty-four cases were admitted for telemetry over the study period. There were 36 events noted to be abnormal, 1 of which required intervention. This patient had an unconfirmed possible threebeat run of ventricular tachycardia and was kept an additional day for observation. One patient was transferred to the ICU for respiratory depression after overdose of an opiate. Twenty-two patients had either a tachyarrhythmia or bradyarrhythmia. No cardiology note was available for 22 charts. Of those, the discharge summary indicated that cardiology reviewed telemetry and there were no events for three patients (LOS 1.3 days, SD 0.58), 13 had no events but did not mention if cardiology reviewed telemetry (LOS 0.92, SD 0.27), 6 did not specifically mention that there were no events (LOS 0.67, SD 0.51. 129 (78.7 %) had EKGs prior to admission and 38 (29.4 %) had a QT >440 ms. Discussion: Only two adverse events requiring intervention were recorded. One was picked up by pulse oximetry monitoring. The other event was unconfirmed and only required additional observation. The majority of events would have been noted by routine cardiorespiratory monitoring. Conclusion: Few events were captured by telemetry in pediatric patients admitted for ingestions. Background: Sumatriptan is a serotonin receptor (5-HT1B and 5-HT1D) agonist and vasoconstrictor that abates migraine headaches. Specialists at U.S. Poison Centers are making clinical judgments regarding pediatric oral sumatriptan ingestions based on very limited data. As the potential complications of any vasoconstrictor may be quite serious, this lack of data presents a unique challenge for those who manage these exposures. Purpose: The purpose of this study was to determine the incidence and types of adverse effects associated with oral sumatriptan in children based on milligram per kilogram exposures. Methods: This is a retrospective review of oral sumatriptan ingestions in children less than 6 years old as reported to the National Poison Data System (NPDS) from the year 2000 through 2010. All cases were followed to a known outcome. Data was categorized based on the certainty of the reported quantity ingested and the severity of clinical outcomes experienced. Results: Out of the 781 total exposures, no major outcomes were reported. There were 427 exclusions due to lack of weight and/or quantity. Of the 354 that met the inclusion criteria, 319 (90.1 %) children experienced no symptoms and 34 ingestions (9.6 %) resulted in minor effects, at average doses of 5. 69 Methods: This is a single-patient case report. A 33-month-old female ingested an unknown quantity of unknown "red berries" and presented to the Emergency Department, with a specimen of the plant. Plant identification was sought by simultaneously forwarding bedside photographs to the Poison Control Center, the State University Herbarium, and by posting them on Facebook®. Results: After 22 min, the Poison Control Center Specialist offered a genus of Solanum, but was unable to further speciate. The genus Solanum includes both harmless and lethal plants. Also at 22 min, the State University Herbarium curator similarly offered the genus Solanum, but cited a lack of size reference as a limit to further interpretation. The Facebook® response was both timely and accurate.The first response, from Norway, occurred within 4 min. At 26 min (4 min after other resources), a specific identification of Solanum dulcamara was proposed, which was subsequently echoed by two additional respondees over four more hours. Images from Google® were compared to our specimen photos, with a very strong semblance. The likely identification of the specimen impacted the toxicologist's recommendation. A definitive identification of Solanum dulcamara was made in 6 days by sending the specimen to the Herbarium curator. Discussion: Crowd-sourced social media offers a new resource for international and widespread input, using digital photographs for plant identification. Conclusion: Crowd-sourced social media websites should be investigated as a resource for timely and accurate identification of unknown plant specimens in medical toxicology consultation.
Acute Aspirin Overdose Managed with Sodium Acetate Due to Sodium Bicarbonate Shortage
Boyd M, Geller R Emory University, Atlanta, GA, USA Background: Traditional treatment modalities for moderate aspirin overdose include urinary alkalinization to enhance salicylic acid excretion. This is traditionally performed by sodium bicarbonate administration. In recent months, sodium bicarbonate has been on shortage and some hospitals have run out of it entirely, resulting in reliance on medication substitutions for treatment. Research question: Is urine alkalinization by sodium acetate an acceptable treatment modality for patients presenting with acute aspirin overdose when sodium bicarbonate is unavailable? Methods: This is a case report of a patient presenting with aspirin overdose to a health care facility where sodium bicarbonate was unavailable due to shortage. Data was collected through the Georgia Poison Center. Results: A 26-year-old male presented to the Emergency Department after an unknown ingestion. Serum aspirin levels were sent due to concern for overdose resulted in a level of 57 mg/dl. The Georgia Poison Center was contacted for management recommendations and notified that sodium bicarbonate was unavailable at the healthcare facility due to shortage. A 150-meq/L sodium acetate infusion was recommended which contained the same anion concentration as found in the traditional protocol. No initial bolus was performed. Labs were collected q2h including VBG, electrolytes, ASA level, and urine ph. Serum and urine were alkalinized without incident. The patient had an uncomplicated hospital course. Acetate infusion was discontinued on hospital day2 when serum ASA levels fell to 19 mg/dl. Discussion: This is a case report of urine alkalinization by sodium acetate for ASA overdose when sodium bicarbonate was unavailable due to shortage. The patient suffered no side effects from this medication which successfully caused both serum and urine alkalinization. Results: Within an hour of ingesting barracuda caught off the coast of Miami, four patients developed gastrointestinal symptoms of varying severity. Among the four patients, two had benign clinical courses and were discharged from the hospital after aggressive fluid resuscitation, while the remaining two had more complicated courses requiring repeated hospitalization. One patient developed atrial fibrillation and syncope, a previously unreported finding. The remaining patient developed severe illness, altered mental status and was intubated for airway protection. A protracted hospital course followed which included hemorrhagic stroke, aspiration pneumonia and tracheostomy placement. The barracuda was obtained and tested through U.S. Food and Drug Administration Chemical Hazards Science Branch which demonstrated that Caribbean ciguatoxin-1 (C-CTX-1) and 2 (C-CTX-2) were present in levels 35 times higher than the 0.1 ppb FDA guidance level. Discussion: This case series demonstrates a highly variable clinical course of four patients that developed ciguatera intoxication after ingesting barracuda that contained both C-CTX-1 and C-CTX-2. This series includes a previously unreported finding of atrial fibrillation as well a description of the prolonged clinical course of a patient that required intubation associated with dehydration and altered mental status. Conclusion: This case series highlights of potential health risks and various clinical outcomes of patients presenting with ciguatoxin poisoning. Background: Ricinus communis toxicity is mediated by the toxalbumin ricin, through ribosomal and protein synthesis inhibition. Morbidity and mortality after ingestion depends on release of the toxin via disruption of the castor bean seed coat, often via mastication or maceration. Due to ricin's rapid metabolism, ricinine (3-cyano-4-methoxy-N-methyl-2-pyridone) is often used as a surrogate marker of exposure. Hypothesis: Ricin toxicity is not predicted by number of beans ingested or by ricinine levels.
Conclusion

Urine Ricinine Levels Following Potentially Fatal Castor Bean Ingestions Do Not Correlate with Clinical Outcomes
Methods: This is a chart review of two patients who self-reported castor bean ingestion in suicide attempts. Patient 1 ingested 30 minced castor beans; 6 h post-ingestion, he developed nausea with two episodes of vomiting. In the ED, decontamination was started with activated charcoal (AC) and whole bowel irrigation (WBI). The patient did not demonstrate any further clinical signs of toxicity. Patient 2 reported ingesting 20-30 beans after grinding them into a fine powder, then mixing and heating in his oatmeal. In the ED, decontamination was initiated with AC and WBI, and the patient suffered only mild GI upset. Serial urine samples were collected from both patients and analyzed using liquid chromatography tandem mass spectrometry (LC/MS/MS). The reported ricinine values are corrected for creatinine level. Results: Ricinine levels are reported in Table I . Discussion: The lethal dose of ingested ricin has been estimated at 1-20 mg/kg of ricin, roughly eight castor beans. We present two cases of large volume castor bean ingestions with the highest ricinine levels reported in the literature. Both patients experienced mild GI upset, but were otherwise devoid of any severe signs of toxicity. Conclusion: Ricin toxicity cannot be predicted by number of castor beans ingested. Although the presence of ricinine confirms ricin exposure, it does not correlate with clinical toxicity. might provide a source of information to characterize newer drugs. As a first step, we sought to correlate Twitter message complexity with previously described data on the educational background of US drug users.
Research question: Do the textual complexity of tweets discussing cocaine, marijuana, or heroin vary? Methods: We queried Twitter for any messages within the USA over 2 months that mentioned the words 'heroin', 'cocaine', or 'marijuana', or a list of established synonyms for those drugs. We applied two measures of textual intricacy-Flesch-Kincaid gradelevel (FK) and Lempel-Ziv complexity (LZ)-to those tweets. FK measures the difficulty of a passage and corresponds to grade level in American schools. LZ measures lexicon diversity and ranges from 1 (no repeated words) to 0 (no word diversity).
Results:
We found the Flesch-Kincaid grade levels were 3.18, 5.2, and 7.03 for heroin, cocaine, and marijuana, respectively. Similarly, the LZ levels were 0.91, 0.70, and 0.54. For comparison, we found the FK grade levels and LZ levels for tweets about coffee to be 8.38 and 0.63, and for beer to be 8.28 and 0.582. Discussion: Our results suggest that tweets about illicit drugs are simpler than tweets about other substances like coffee and beer. Marijuana tweets showed a higher grade level but lower lexical diversity than tweets about cocaine, which in turn were more sophisticated but less diverse than heroin. Lexical diversity data correlates better with existing surveys on illicit drug users' age and education. Applying textual analysis tools to tweets may be useful for the toxicovigilance of emerging drugs of abuse.
Laundry Detergent Colitis
Conroy MJ, Menke NB, King AM, Lynch MJ University of Pittsburgh, Pittsburgh, PA, USA Background: Colitis has been shown to occur following rectal administration of laundry detergent enemas. Although caustic injury of the pharynx and esophagus has been observed following oral ingestions, laundry detergents have not been previously documented as causing colitis following oral ingestion. Hypothesis: Oral ingestion of laundry detergent can cause colitis.
Methods: This is a single-patient chart review. A 71-year-old woman with a history of anxiety was witnessed ingesting an unknown amount of liquid laundry detergent (All® brand) in a suicide attempt. The patient was afebrile, tachycardic, and had active emesis. She appeared uncomfortable and complained of abdominal pain, nausea, mouth and throat pain. The patient had diffuse abdominal tenderness without peritoneal signs. Her physical exam was otherwise unremarkable. The patient developed foamy diarrhea. A CT scan of the patient's chest, abdomen, and pelvis revealed diffuse colonic mucosal hyperenhancement and mild wall thickening compatible with pan-colitis. They were no injuries identified on esophagogastroduodenoscopy.
Initial therapy involved anti-emetics, proton-pump inhibitor, and fluid resuscitation. By hospital day2, the patient's abdominal pain and leukocytosis resolved. Her diet was slowly advanced. The patient was discharged to a psychiatric facility on hospital day5 without complications.
Results: Lab work revealed a leukocytosis of 17×10 9 /L [3.8-10.6] and an anion gap of 24. Her urine drugs of abuse screen was negative. Her venous blood gas measured pH7.43, HCO 3 23 meq/L, with a base deficit of 0 meq/L. Her lactate measured 1.7 mMol/L [0.5-2.2]. Discussion: Recognized as a complication of detergent enemas, colitis is not a previously reported consequence of oral ingestion. Pan-colitis should be considered when patients present with abdominal pain following oral ingestion of detergents. Patients can be treated with supportive care. Conclusion: We report the first case of colitis due to the ingestion of laundry detergent.
Methemoglobinemia in a Child with Short Gut Syndrome and Bacterial Overgrowth
Davidson C, King AM, Menke NB, Katz KD University of Pittsburgh, Pittsburgh, PA, USA Background: Methemoglobinemia is commonly caused by ingestion of drugs or other oxidizing xenobiotics, such as nitrates. Case reports have described significant methemoglobinemia in the context of acute diarrheal illness and dehydration but usually in infants, the effects of methemoglobin levels above 70 % in this scenario have not been previously described. Hypothesis: Life-threatening methemoglobinemia may be caused by bacterial overgrowth in susceptible children. Methods: This is a single-patient chart review. A 29-month-old girl with "short gut syndrome" secondary to gastroschisis and subsequent recurrent Clostridium difficile bacterial overgrowth presented to a local hospital after being found gray and unresponsive by family. She received total parenteral nutrition and her medications included oral vancomycin and intravenous famotidine. At the receiving institution, her vital signs were: blood pressure 82/40 mmHg, heart rate 170 bpm, respiratory rate 50, and pulse oximeter 77 % on 15-L non-rebreather, Hemoglobin measured 7.8 g/dL, and methemoglobin 72.7 %. She was administered 2 mg/kg methylene blue, 15 mL/kg packed red blood cells, normal saline, and antibiotics. She was transferred to a tertiary care children's hospital where she made a full recovery. Repeat methemoglobin level was 2 %. A urine gas chromatography/mass spectrometry qualitative drug screen detected no other xenobiotics. Her home drinking water tested negative for all nitrates. Discussion: Existing reports describe diarrhea-associated methemoglobinemia in infants under 6 months up to 57 %. No other substances were found to be responsible for this profound methemoglobinemia including medications and nitrates in her drinking water. Oxidative stress from gastroenteritis or other infections may cause methemoglobinemia in infants due to low cytochrome-b5 reductase activity and/or concentrations. Conclusion: Life-threatening methemoglobinemia may be caused by bacterial overgrowth in children with short gut syndrome. Physical exam revealed 3+ reflexes, tremulousness, and lower extremity rigidity without diaphoresis. The assays for aspirin, acetaminophen, ethanol and drugs of abuse returned negative, with normal CBC and CK levels. The BMP was normal except K03.2. She received oral lorazepam 2 mg every 8 h for 2 days. She did not develop hyperthermia and her symptoms resolved within 24 h. The serum concentration of asenapine drawn at presentation was 42 ng/mL. The therapeutic limit is 1 ng/mL.
Serotonin Syndrome Secondary to Sublingual Saphris
Case Discussion: Asenapine is dosed at 5-10 mg sublingually twice daily with a maximum of 20 mg per day. The bioavailability of therapeutic doses is 35 and <2 % when taken orally. The peak absorption is 0.5 to 1.5 h with an elimination half-life of 24 h when administered sublingually. As an antipsychotic, asenapine may cause CNS depression, hypotension, prolonged QT intervals and neuroleptic malignant syndrome. Conclusion: Atypical anti-psychotics have been touted to be safer to use in patients requiring dopamine antagonism, but through their partial agonism of serotonin (5HT1A) receptors, complications arise in both overdose and in coadministration with other serotonergic agents. An acute overdose of 200 mg of sublingual asenapine produced moderate serotonin syndrome.
Continuous Octreotide Infusion Effectively Prevents Hypoglycemia in Resistant Pediatric Sulfonylurea Toxicity
Escajeda JT, King AM, Menke, NB, Katz KD, Pizon AF University of Pittsburgh, Pittsburgh, PA, USA Background: Octreotide is a commonly employed therapy for sulfonylurea toxicity. Recommended doses range from 25-100 mcg q6-q8 h for adults and 1-1.5 mcg/kg SQ q6h for children. Despite these doses, dextrose infusions are often required and recurrent hypoglycemia is common. Hypothesis: Octreotide is underdosed in the setting of sulfonylurea toxicity resulting in unnecessary hypoglycemic events. A continuous infusion is a safe and efficacious alternative that prevents the need for dextrose infusions and recurrent hypoglycemia.
Methods: This is a single case report.
Results: A 23-month-old girl was given approximately 35 mg of her grandmother's glyburide by her older sister and presented lethargic with a capillary glucose of 36 mg/dL. She was given 48 mL 10 % dextrose bolus and started on a D10 NS infusion at 35 mL/h. The patient had recurrent hypoglycemia (<60 mg/dL), despite administration of 1 mcg/kg SQ octreotide. An octreotide infusion was started at 5 mcg/kg/h, however, episodic hypoglycemia persisted and the dose was titrated to 10 mcg/kg/h over 5 h. After 11 h, the octreotide and dextrose infusions were discontinued and she was monitored for 24 h longer, with no further hypoglycemic events Discussion: This patient was administered larger doses of octreotide than is currently recommended for sulfonylurea toxicity. Pediatric octreotide doses for gastrointestinal bleeding and secretory diarrhea are as high as 2 mcg/kg/h, such doses have an excellent safety profile. An octreotide infusion may be required if recurrent hypoglycemia occurs in sulfonylurea toxicity in order to avoid insulin release stimulated by high concentration dextrose drips. Conclusion: Octreotide infusion is safe and effective in treating refractory sulfonylurea-induced hypoglycemia. Background: Clonidine overdose is classically characterized by initial hypertension due to peripheral alpha-2 agonism followed by hypotension and bradycardia due to central alpha-2 agonism. Hypothesis: We hypothesize that persistent hypertension with bradycardia can be an atypical manifestation of acute clonidine overdose. Methods: This is a single-patient chart review. A 14-month-old male presented with a history of persistent somnolence after going down for his nap 7 h prior. There was no history of ingestion but the father was prescribed a clonidine patch. Throughout the following 36 h, the patient remained very somnolent and was persistently bradycardic and hypertensive, with numerous systolic blood pressures (SBP) recorded near or above the upper limit of normal for that age. Heart rate reached a nadir of 61 beats/min at which time SBP was 113 mmHg. Two milligrams of naloxone was administered which elicited a delayed and transient response during which, 10 min after administration, the patient woke up and cried for 2-3 min and heart rate increased to 110 beats/min, followed by a rapid return to somnolence and bradycardia. Results: A rapidly obtained comprehensive drug panel was positive for clonidine, at which point activated charcoal was administered and whole bowel irrigation was performed with polyethylene glycol via nasogastric tube. A clonidine patch was recovered in the stool on hospital day2 and symptoms began to resolve about 36 h after presentation. Discussion: This is an atypical presentation of confirmed clonidine ingestion in a 14 month old characterized by hypertension and bradycardia. The physiological mechanism of these findings is unclear, but it is possible that prolonged absorption of relatively low amounts of clonidine from the gut produced persistent peripheral alpha-2 agonism without significant central sympatholytic effects. Conclusion: CNS depression with persistent hypertension and bradycardia is a potential presentation of clonidine toxicity in a child.
Efficacy and Safety of Physostigmine for Anti-cholinergic Delirium from Psychotropic Drugs
Gunja N NSW Poisons Information Centre, Sydney, Australia Background: Physostigmine has been shown to be effective in managing delirium from anti-cholinergic poisoning. While this has been accepted for pure anti-muscarinic drugs, psychotropics with multiple mechanisms of action such as cyclic anti-depressants and antipsychotics also cause delirium from muscarinic blockade. Physostigmine use in this setting has been cautious or avoided by clinicians due to concerns of cardiac toxicity since a cardinal report in 1980. Hypothesis: Physostigmine is an effective and safe antidote for anticholinergic delirium from psychotropic drugs. Methods: Literature search in was done Medline, PubMed, Google Scholar and Embase since 1980, using search terms "physostigmine" AND "reversal" or "delirium". Case reports or series describing the use of physostigmine for the management of acute delirium from drug overdose were selected. Review, non-human and non-English language articles were excluded, as well as reports involving pure anticholinergic poisoning was also made. Results: Since 1980, 117 cases of physostigmine use in non-pure antimuscarinic poisoning complicated by delirium have been published. The drugs implicated were anti-psychotics, anti-depressants, antihistamines, anesthetic agents, opiates, and GABA-ergics. There were also 44 cases where the drug involved was unknown and physostigmine was used as a diagnostic agent. Discussion: The caution against physostigmine in psychotropicinduced anti-cholinergic delirium is based on a few case reports. Physostigmine appears to be most effective when treating delirium from drugs known to block central muscarinic receptors. Other than failure of resolution of delirium, few adverse events have been reported from physostigmine use in delirium. Conclusion: Physostigmine is likely to be most effective in managing delirium from central muscarinic receptor blockers, and appears safe when administered outside the period of cardiac toxicity from psychotropics. Its efficacy in delirium caused by non-muscarinic receptor blockers, delirium of unknown cause, or in post-anesthetic delirium remains doubtful.
Utility of Liver Dialysis Therapy in Drug-Induced Hepatotoxicity
Halliday MH, Subramanian RM, Morgan BW Emory University, Atlanta, GA, USA Background: Management of acute liver failure (ALF) due to druginduced hepatotoxicity traditionally involves intensive supportive care and the use of N-acetyl-cysteine (NAC). The Molecular Adsorbent Recirculating System (MARS) albumin dialysis is an emerging therapy for drug-induced hepatotoxicity. Aim: The aim of this study was to assess the safety and efficacy of MARS in the treatment of ALF due to drug-induced hepatotoxicity, as a bridge to native hepatic recovery.
Methods: This is a retrospective case series. Three patients with drugassociated ALF (two acetaminophen and one possible clarithromycin) who presented greater than 24 h after the onset of hepatic encephalopathy are discussed. ALF was defined as the presence of hepatic encephalopathy and INR greater than 1.5. All patients were not candidates for liver transplantation due to underlying psychiatric disorders. In addition to NAC therapy, all patients underwent 8 h sessions with the MARS hemofiltration system on three consecutive days. AST, ALT, INR, total bilirubin, pH, ammonia, and hepatic encephalopathy scores were recorded prior to treatment, after each session and after protocol completion. Treatment was completed using simultaneous albumin dialysis and renal replacement therapy with citrate anticoagulation. Results: All three patients presented with hyperammonemia (range 63-114), and coagulopathy (INR range 1.74-4.1). After MARS treatment, all patients had improvement of hyperammonemia (range 36-56), improvement in presenting encephalopathy and a resolution of coagulopathy. No complications from MARS therapy were noted. All three patients survived to discharge with clinical and biochemical improvement. Discussion: These three cases demonstrate the safety and potential efficacy of liver dialysis in ALF due to drug-induced hepatotoxicity. Prospective randomized controlled studies are needed to further examine the efficacy of MARS in ALF. Conclusion: Liver dialysis is a promising therapy in the treatment of ALF due to drug-induced hepatotoxicity, and may reduce mortality and the need for liver transplantation by facilitating native hepatic recovery. Table 1 . A total of 202 cases of laundry detergent packet exposures were identified after 29 were excluded for miscoding. Monthly totals increased in successive months. The median age was 2 years. Most cases (116) were managed at home. Among 86 cases resulting in healthcare facility visits, 14 children required hospital admission, with five admitted to a pediatric intensive care unit. Hospitalizations ranged 1-6 days. Gastrointestinal, respiratory, metabolic, and neurologic effects were prominent. Endotracheal intubation was required in one case. Two brand name products were disproportionately responsible for the moderate and severe effects. Discussion: Laundry packet ingestions represent an important new pediatric ingestion hazard with the potential for gastrointestinal, neurologic, metabolic, and ocular effects. More studies are needed to explain the toxic mechanisms of these products, and to identify strategies to treat exposure complications. Study limitations include selection bias and inadequate follow-up in some cases. Conclusion: Clinicians should be aware that while most liquid laundry detergent exposures cause minor effects, they occasionally result in severe toxicity. Surveillance, prevention, and parental education efforts should focus on these new hazards. Background: Carisoprodol is a centrally acting muscle relaxant commonly used for the treatment of musculoskeletal disorders. While seizure in carisoprodol overdose has been reported, it is uncommon. In contrast, myoclonus is reported with carisoprodol toxicity. Distinguishing the two entities at the bedside, however, can be exceedingly difficult.
Hypothesis: Severe carisoprodol-induced myoclonus may be misdiagnosed as seizure activity.
Methods: This is a single-patient chart review. A 25-year-old woman with a history of IV heroin abuse and chronic back pain presented to the Emergency Department after carisoprodol overdose. She was found sedated with empty pill bottles. Upon arrival, the patient was unresponsive, had severe vertical nystagmus, and vigorous, whole body jerking movements. She was intubated for airway protection and started on a propofol infusion. Despite this, she continued to exhibit these movements, requiring adjunctive lorazepam, midazolam, and phenobarbital. Results: A brain CT was obtained, which was unremarkable. Serum ethanol, salicylate, TCA, and acetaminophen concentrations were unmeasureable. An EMIT urine drug screen of abuse detected opiates, benzodiazepines, and methadone. Due to concern for seizure activity, the patient was administered both levecitiram and phenytoin, and an EEG was performed, which demonstrated midline frontal spikes consistent with myoclonus and not seizure activity. A urine comprehensive drug screen (GC/MS) measured a very large peak of carisoprodol. Tremors and ocular nystagmus resolved within 24 h of the patient's ingestion, and the patient was successfully extubated. Repeat EEG showed no epileptiform discharges, and she was transferred to inpatient psychiatry. Discussion: Carisoprodol is well-known to cause myoclonus, altered mental status and hypotension in overdose. The myoclonus may be vigorous and confused with seizures. Conclusions: Patients who present with carisoprodol toxicity may exhibit vigorous myoclonus which may be confused with seizures. Treatment with antiepileptic medications in these instances is of no benefit and not indicated. Methods: This is a single-patient chart review. A healthy 17-year-old woman ingested twenty 100 mg benzonatate tablets in a suicide attempt. She was found unresponsive, pulseless, and in ventricular fibrillation by EMS. The patient was defibrillated at 150 J on scene with return of spontaneous circulation in sinus tachycardia. The initial urine drug screen of abuse (EMIT II Plus, Siemens) was reported as inconclusive due to an interfering substance. A urine gas chromatography/mass spectrometry qualitative drug screen demonstrated a large peak of benzonatate and polyethylene glycol. The patient was admitted to the ICU for 2 days and received supportive care. The patient had full neurologic recovery and was discharged without complications to a psychiatric facility on hospital day3. Discussion: Benzonatate is structurally similar to the ester class of local anesthetics for which treatment includes fat emulsion therapy. This case report details a case of benzonate ingestion resulting in ventricular fibrillation responsive to defibrillation. There does not appear to be a benefit to implementing fat emulsion therapy in patients that convert to a stable rhythm after electrical therapy. Polyethylene glycol that is used as an excipient in the benzonatate tablet may act as an interfering substance in the urine drug screen. Conclusions: (1) Patients who respond to defibrillation in benzonatate ingestion do well with supportive therapy and have short-lived toxicity.
Hydrofluoric Acid Exposures That Burn the Physician
(2) The urine drug screen in benzonate overdose may show polyethylene glycol as an interfering substance.
Which Psychiatric Patient Will
Have an "Occult" Acute Aspirin or Acetaminophen Overdose?
Lee DC, Weiselberg R, Loftus BS, Bailey K, Hardial M, Su M, Biello L, Ward M, Poncher E Northshore-LIJ Health System, Manhasset, NY, USA Introduction: Patients who present with acute ASA/APAP overdose and who may not offer an accurate history can be difficult to treat. We sought to determine the prevalence of and demographic characteristics of these types of patients in a cohort of subjects with a high risk of "occult" acute overdose.
Methods: We performed a retrospective chart review of all patients who presented with a primary psychiatric complaint to the psychiatric area of an academic, suburban, Emergency Department (annual census 85,000) between September 19, 2010 and September 30, 2011. At our institution, patients are routinely screened for ASA/APAP levels for appropriate psychiatric care ("medical clearance"). We defined all patients with supra-therapeutic levels as an acute overdose. We excluded subjects who presented hemodynamically unstable or admitted to overdose of ASA/APAP-containing products on presentation.
Results: Of 1,133 patients presenting to the psychiatric area of the ED in this time period: 741 received ASA/APAP screening (65.4 %). Of the 741 patients receiving ASA/APAP screening, 675 had both ASA and APAP screening (91.1 %, mean age 39.1 SD 16.4, 49.6 % male). Fifty-four had only APAP screening (7.3 %, mean age 44.6±16.0, 35.2 % male). Twelve had only ASA screening (1.6 %, mean age 36.0±12.0, 50.0 % male). One subject had an occult supra-therapeutic ASA level (70.6 μg/mL) prevalence 0.13 %. Two subjects had an occult supra-therapeutic APAP level (35, 124 μg/mL) prevalence 0.27 %. Of the three subjects, two required immediate management changes. Although these three subjects tended to be younger (26, SD 2.0, 66 % male) as compared to their counterparts, this was not statistically significant (p00.17). Conclusion: A prevalence rate of 0.13 and 0.27 % for supratherapeutic ASA/ APAP levels is consistent with prior studies describing patients who were unable to give appropriate histories and presented with occult overdoses. In this cohort, we could not determine differences in the age or gender.
Sudden Onset Bilateral Sensorineural Hearing Loss Following Fentanyl Overdose
Lester TP, Wiegand TJ University of Rochester, Rochester, NY, USA Background: Previous case reports have described the association of sudden onset sensorineural hearing loss with the abuse of opioids including heroin, methadone and hydrocodone. This phenomenon has been termed 'opioid-associated hearing loss' or OAHL. Hypothesis: Like previously described opioids, fentanyl abuse can be associated with sudden onset bilateral sensorineural hearing loss.
Methods: This is a single-patient chart review. A 26-year-old previously healthy male who had been released from jail 5 days previously was found obtunded by his mother after he snorted three 50 μg fentanyl patches. He was given naloxone with reversal of sedation. When he awoke, he complained of difficulty hearing. Bedside testing confirmed moderate bilateral sensorineural hearing loss. The hearing loss slowly improved over time and by the time of discharge 24 h later, it had resolved completely.
Results: Urine drug screen confirmed presence of fentanyl. Discussion: Fentanyl and other opioids are common drugs of abuse, and have many well-described side effects. Although rarely reported, these opioids have been associated with bilateral sensorineural hearing loss. The mechanism is poorly understood, but cases have included both irreversible as well as short term hearing loss with improvement over a period of days.
Conclusion: Abuse of opioids should be considered in patients presenting with abrupt onset sensorineural hearing loss. Methods: This is a single-patient chart review. A healthy 21-yearold male presented to the ED with gross, painless hematuria and petechiae and was subsequently found to have an undetectable platelet count. He had begun taking a weight-loss supplement, VPX Meltdown TM , 4 days earlier and noticed petechiae within 24 h of the first dose. He denied use of any other chronic medications and took two aspirin tablets for a headache the day before presenting to the ED. During his hospital stay, the patient received intravenous immune globulin, high-dose methylprednisolone, and platelet transfusions. Bone marrow biopsy revealed changes consistent with idiopathic thrombocytopenia (ITP). Results: Tests for HIV and CMV were negative. The patient was discharged to hematology follow-up with a platelet count of 26×103/ mm 3 . In the following months, his platelet counts fluctuated, seeming only to respond to high-dose steroids. Upon tapering steroids, his platelet count dropped from a peak of 95×10 . Gas chromatography/mass spectrometry analysis of the supplement confirmed two PEA analogs in addition to caffeine and yohimbine. Discussion: VPX meltdown TM contains R-beta-methylphenylethylamine and N-methyl-B-phenylethylamine. This case may suggest that newer synthetic PEA stimulants, such as cathinones, may also have the potential to cause DITP. Conclusion: The PEA analogs in this weight-loss supplement may have been responsible for this patient's thrombocytopenia, ITP remains on the differential, but the temporal relation to starting the supplement and lack of other causative agents warrants continued surveillance and awareness of such cases.
A Case of Ethylene Glycol Poisoning Presenting as an ST Elevation Myocardial Infarction
The Incidence of CYP2D6 and CYP2C19 Medication Interactions In Emergency Department Patients
Monte AA, Campbell J, Vasillou V, Heard KJ University of Colorado, Aurora, CO, USA Background: The hepatic cytochrome 2D6 (CYP2D6) is a saturable enzyme responsible for metabolism of approximately 25 % of known pharmaceuticals. CYP interactions may alter the efficacy and safety of prescribed medications and are not identified by medication interaction tools. The analgesic efficacy of hydrocodone is dependent upon CYP2D6 metabolism to hydromorphone. Many antibiotics, anticoagulants, and anti-hyperglycemics are 2C19 substrates yielding significant opportunity for interaction. Objective: The purpose of this study was to determine incidence of CYP2D6 and CYP2C19 medication interactions in a cohort of ED patients. Methods: A convenience sample of ED subjects was prospectively enrolled between June 1, 12 and October 31, 12. Subjects were included if they had self-reported pain or nausea. Exclusion criteria were patients who were unable to speak English, <18 years old, or previously diagnosed with chronic pain or cyclic vomiting. Detailed medication histories for the preceding 48 h prior to ED visit were obtained. Baseline pain and pain between 30 and 90 min after hydrocodone administration (as part of ED care) was quantified by visual analogue scale (VAS). Descriptive statistics were used to characterize the incidence of CYP2D6 and CYP2C19 interactions. This abstract represents the interim analysis of the initial 333 subjects in the dataset. Results: Three hundred thirty-three of 446 subjects were consented (74.7 % consent rate). The median age was 39 years (range 18-89; IQR, 27, 52), and 36.0 % were male. One hundred fifty-three (45.9 %) patients were on ≥1 CYP2D6 medication and 65 (19.5 %) were on ≥2 CYP2D6 medications. Twenty-eight (7.8 %) of patients were on ≥1 CYP2C19 medications. There was a trend toward decreased VAS change in patients receiving hydrocodone and taking ≥1 CYP2D6 substrates or inhibitors. Conclusions: CYP2D6 medication interactions are common. Initial results suggest decreased hydrocodone efficacy in patients taking ≥1 CYP2D6 substrates or inhibitors. CYP2C19 interactions are less common but may yield clinically significant interactions due to the highrisk medications dependent on this enzyme.
Marijuana Utilization in ED Patients in an Area with High Marijuana Availability
Monte AA, Campbell J, Vasillou V, Heard KJ University of Colorado, Aurora, CO Background: Marijuana utilization has become increasingly prevalent in states that have passed legislation increasing the availability of medical marijuana. As of October 2012, 17 states allow for consumption of marijuana for the treatment of a range of medical diagnoses defined at the state level. Objective: The purpose of this study was to determine the incidence of marijuana utilization in a cohort of ED patients presenting with pain or nausea in an area with high marijuana availability. Methods: A convenience sampled cohort of ED subjects were prospectively enrolled between June 1, 2012 and October 31, 2012. Subjects were included if they had self-reported pain or nausea. Patients were excluded if they were unable to speak English, were less than 18 years of age, or carried a diagnosis of chronic pain or cyclic vomiting. Detailed illicit drug ingestion histories for the preceding 48 h prior to ED visit were obtained. Descriptive statistics were used to analyze demographic and incidence data. Odds ratios and chi square were calculated to determine demographics associated with marijuana utilization. Results: Three hundred thirty-three of 446 were consented (74.7 % consent rate). Overall, the median age was 39 years (range 18-89; IQR, 27, 52), and 36.0 % were male. Thirtyseven (11.1 %) endorsed using marijuana in the previous 48 h prior ED visit. In this group, the median age was 32 (range 19-70; IQR 25, 48) and 48.6 % were males. While there was a trend for users to be male, the association did not reach statistical significance (OR01.8, 95 % CI 0.91, 3.58) . The median test did not identify a statistical association with age (p00.077). There was no association with race or ethnicity. Conclusions: Marijuana utilization was observed in more than 10 % of patients across all demographics. There was a trend toward users being younger males though use occurs in all demographics. Physicians should educate patients about the health risks of marijuana. Results: Fifty patients were included (average age 50.2 years). Alcohol levels were detectable for 28 patients with average 197 mg/dl (range 10-530). Forty-nine patients were treated with adjunctive agents, the most common being: anti-psychotics (n0 34), opioids (n014), clonidine (n024), and phenobarbital (n016). Average day of FMZ administration was 4.6 (range 1-10) and dose was 0.5 mg (range 0.2-1). At the time of FMZ administration, delirium was described as over-sedate (n032), intermittently agitated (n033), or both (n030). Thirty-six (85.7 %) patients had objective improvement after receiving FMZ. Twenty-seven patients required more than one dose (average 6.2 doses over 1.5 days). There were no adverse events. Discussion: This is the largest series of patients receiving FMZ to diagnose BZD-delirium after AWS. The safety profile for our patients may be explained by (1) presence of adjunctive agents such as phenobarbital, and (2) reducing initial dose of FMZ, if administered before day4. During the treatment of AWS, if delirium is present on day5, a test dose of FMZ may be considered to rule out BZD-Delirium. Conclusions: FMZ can safely diagnose BZD-delirium during the treatment of AWS for our patients.
Flumazenil to
Early Non-Detectable Acetaminophen Levels in Patients
Requiring N-Acetylcysteine Therapy Neavyn MJ, Carey JL, Rhyee SH, Ward JA University of Massachusetts, Worcester, MA, USA Background: Oral acetaminophen (APAP) is rapidly absorbed in the small intestine. An initial, non-detectable serum APAP concentration often reassures clinicians of a benign ingestion. The following cases demonstrate that a non-detectable APAP level performed earlier than 4 h post-ingestion may not rule out APAP toxicity.
Case series: Case 1: A 35-year-old woman with a history of bipolar disorder reported ingestion of 50 tablets of Tylenol PM® (APAP 500 mg/diphenhydramine 25 mg). The patient's APAP level was <10 mcg/mL 1 h after ingestion. The patient had no significant exam findings and was admitted to psychiatry. A comprehensive toxicology panel later reported the presence of APAP, diphenhydramine, and venlafaxine. This prompted an APAP level at 14 h post-ingestion, which was 51 mcg/mL, and a continuous infusion of N-acetylcysteine was started. The patient completed the course of treatment with no negative sequelae. Case 2: A 38-year-old woman ingested an unknown amount of Tylenol PM® (APAP 500 mg/diphenhydramine 25 mg) with alcohol. She complained of abdominal pain and nausea. Her exam was notable for mild delirium and agitation, tachycardia, active bowel sounds, and moist axillae. A serum APAP level was <10 mcg/mL 2 h after ingestion. At 4.5 h, her serum APAP level was 203 mcg/mL, and a continuous infusion of N-acetylcysteine was started. Afterward, the patient had an uncomplicated hospital course. Discussion: The two cases reported here demonstrate the delay in APAP absorption that can occur with co-ingestants known to delay gastric emptying. Clinicians who rule out acetaminophen toxicity based on a non-detectable level obtained earlier than 4 h after ingestion may fail to identify patients in whom N-acetylcysteine therapy is mandated. Conclusion: Early undetectable serum levels of acetaminophen obtained at less than 4 h after ingestion are insufficient to rule out toxicity, particularly in the setting of co-ingestants that may delay gastric emptying.
Thrombotic Thrombocytopenic Purpura and Injection Use of Oxymorphone: Elucidating the Mechanisms
Neavyn MJ, Zuckerman MD, Carey JL, Boyer EW, Babu KM University of Massachusetts, Worcester, MA, USA Introduction: Thrombocytopenic thrombotic purpura (TTP) is a rare, life-threatening disease of unknown etiology. Endothelial injury plays a role in the pathogenesis of TTP; however, only a single case of heroin-associated TTP has been reported in the English medical literature. Recently, 12 TTP cases were associated with injection of antidiversion formulated oxymorphone (Opana with Intac® technology, or ADF-oxymorphone) for non-medical purposes. This ADFoxymorphone contains polyethylene oxide, polyvinyl alcohol and talc, no cases of TTP after oral administration have been described. Question: The goal of this study is to categorize methods of ADFoxymorphone manipulation for injection use, and to hypothesize potential risk correlates with TTP. Methods: We analyzed crowd-sourced drug diversion data trends (Bluelight.ru), identifying methods of manipulating ADFoxymorphone and modes of administration. We specifically queried a mega-thread related to the newest ADF-oxymorphone, which was commonly cited within other forums. The forum thread was extracted from the website and data was collected in Excel ® spreadsheets. We classified content on methods for modifying the ADF-oxymorphone formulation, or proscriptions against such practices. We then compared crowd-sourced data against known physicochemical properties of the components of ADF-oxymorphone. Results: The most commonly recommended extraction methods were solute extraction (21.6 %), microwaving/freezing (15.7 %), and grinding (13.7 %). Crisping was reported by 3.9 %. Several commenters (11.8 %) directly advised against manipulating the drug, even after suggesting methods (see Table 1 ). PEO pyrolysis produces ethylene oxide monomers, which have been implicated in hypersensitivity and immune sensitization reactions. The physicochemical characteristics of polyethylene oxide allow it to form lamellar liquid crystal structures in aqueous media. Conclusions: Heating of ADF-oxymorphone causes production of the ethylene oxide monomer, which produces immune sensitization and thrombocytopenia. The incompatibility of other liquid crystals with human blood suggests that similar studies are essential in understanding the role of intravenous PEO in causing TTP. Hypothesis: Lipemia from LRT can interfere with analysis of liver function tests. Methods: In this case report, we perform a chart review of a single patient treated with LRT after drug ingestion. Results: A 54-year-old male with a history of depression consumed unknown amounts of diphenhydramine, amitriptyline and acetaminophen (APAP). Initial work-up showed AST of 138 U/L, APAP 177 mcg/ml, and a QRS interval of 136 ms. N-acetylcysteine (NAC), sodium bicarbonate, and 20 % intravenous LRT (100-ml loading dose, infusion of 0.25 mL/kg/min) were initiated. Labs drawn less than 6 h later showed an APAP 44 mcg/ml and an undetectable AST (Siemens Vista 1500 analyzer, lower limit of detection: ALT06 U/L, AST03 U/L). NAC and LRT infusions were stopped. Eight hours later, serum AST was measured at 488 U/L, and increased over the next two days to a peak of 1,600 U/L before recovery. Discussion: Given a gradually rising course of AST following APAP ingestion, a single undetectable measurement is highly unlikely and probably erroneous. NAC and sodium bicarbonate have not been reported to interfere with liver enzyme assays. However, for this Siemens analyzer, serum lipid concentrations greater than 400 mg/dL cause interference with the AST measurement. Because lipid levels greater than 400 mg/dL with other similar analyzers are known to falsely decrease the AST, it is possible that extreme lipemia caused this laboratory result, a triglyceride level of 3,648 mg/dL has been reported after LRT infusion. This conclusion is limited by the lack of repeat measurement of liver enzymes or measurement of serum lipid levels, it is also possible that the blood sample was drawn from the line infusing LRT. Background: Angiotensin-receptor blockers (ARBs) are commonly prescribed anti-hypertensive medications. There is a paucity of literature describing overdose with these drugs. We describe a case of a 30-year-old male who developed hypotension and acute kidney injury after an intentional ingestion of losartan and telmisartan. Case Report: A 30-year-old male with no prior history, arrived via emergency medical services after patient intentionally ingested a total of 1.25 g (25 tablets of 50 mg) losartan and 1 g (25 tablets of 40 mg) of telmisartan, neither of which was his own medication. Initially he had a heart rate of 105 bpm and a blood pressure of 130/72 mmHg. Approximately 3 h from presentation, he developed mild hypotension with a blood pressure of 88/43 mmHg. It resolved with intravenous fluids administration. On laboratory evaluation, his initial creatinine was 0.91 mg/dL approximately 1.5 h after ingestion. It increased to 1.35 mg/dL at 10 h post-ingestion, 1.41 mg/ dL after 12 h, and subsequently plateaued at 1.5 mg/dL 36 h after his ingestion despite normal saline hydration of 250 ml/h over that time period. He was discharged from the hospital in stable condition but was lost to follow-up. Losartan, losartan metabolites, and telmisartan were confirmed in the patient's serum by liquid chromatography-time of flight mass spectrometry analysis. No other drugs were detected. Discussion: Overdoses of losartan and telmisartan are rarely reported. Hypotension and acute kidney injury has not been previously reported in the literature with regard overdoses of these agents alone. The delayed and prolonged serum creatinine elevation seen in this case suggests that repeat kidney function tests may be warranted in cases of large ARB ingestions. Further research is needed to determine appropriate testing intervals.
Intentional Lamotrigine Overdose Leading to Prolonged Elevation in Serum Lamotrigine Concentrations and Serotonin Syndrome
Shulman JA, King AM, Abesamis MG University of Pittsburgh, Pittsburgh, PA, USA Introduction: Experience with the effects of lamotrigine in overdose is limited. Previous case reports describe cardiovascular toxicity, seizures, and altered mental status. Lamotrigine toxicity presenting with serotonin syndrome and a significant delay in peak serum concentration have not been described. Hypothesis: Lamotrigine can cause serotonin syndrome, furthermore, in overdose, patients may have significant delays in time to peak serum lamotrigine concentration. Methods: This is a single-patient chart review. A 53-year-old man was found unresponsive in the woods approximately 12 h after ingestion of a homemade "slurry" of dissolved prescription medications found at the scene. His known prescription medications included lamotrigine, bupropion, zolpidem, phenytoin, and alprazolam. During air transport, he had one seizure-like episode. On assessment, had a temperature of 35.4°C, heart rate 76 bpm, a respiratory rate 12/min, and blood pressure 114/74 mmHg. His physical examination was significant for altered mental status, lower > upper extremity rigidity with bilateral sustained clonus, and hyperreflexia. Electrocardiogram revealed normal intervals. Phenytoin was undetectable. Initial serum lamotrigine level was 29.4 μg/mL (normal high <20 μg/mL) and subsequent levels demonstrated a peak concentration of 41.7 μg/mL on HD 3 (see Table 1 ). Gas chromatography/mass spectrometry revealed lamotrigine, zolpidem, nicotine, and caffeine. He was intubated for airway protection from HD 2 to HD 9. He made a full recovery and was discharged on HD 14. Discussion: Lamotrigine's purported mechanism of action includes voltage-gated sodium channel blockade and regulation of glutamate release. Inhibition of 5-HT uptake has been demonstrated in rats which makes the clinical presentation of serotonin syndrome mechanistically plausible. Finally, this is the latest a peak serum concentration of lamotrigine following overdose that has been reported. Conclusion: Lamotrigine causes serotonin syndrome and peak serum concentrations may be significantly delayed. Background: A recent study showed that 58 % of calcium channel blocker (CCB) poisoning cases are not treated according to the Poison Control Center's (PCC) recommendations. Purpose: The objective of this study was to evaluate if the opinions of emergency physicians regarding the treatment of CCB poisonings are influenced by their training and practice setting. Methods: A survey was conducted among emergency physicians working in the Province of Quebec (September 2008 to 2011). A weight-based group sampling method was used to identify the emergency departments (EDs) where clinicians were invited to participate. During one of the ED meetings, clinicians were asked to select their management for six diltiazem-poisoning scenarios, and identified which resources were available at their hospital and possible influencing factors on their management strategies. Results: A total of 140 emergency physicians (19 EDs) participated in the study. A greater proportion of FRCPC(EM) and CCFP(EM) clinicians considered the administration of calcium and high-dose insulin euglycemia therapy (HIET). Clinicians from secondary and tertiary centers were also more prone to include these approaches. Family physicians (FPs) and those in primary centers ordered atropine and external pacemaker in a greater proportion. The reported unavailable resources varied mainly depending on the practice setting. Only FPs mentioned the PCC as an influence on their management strategy.
Discussion: Participants may be subject to desirability bias. Nevertheless, the previously mentioned retrospective study identified that HIET was often not started when indicated, consistent with results in the survey in this report, and decontamination seemed to be erratic, as reflected in the diversity of reported approaches in this study. Therefore, this suggests that the physicians' responses may indeed reflect how they would manage a real case. Conclusion: The emergency physicians' opinion regarding treatment of CCB poisoning can be influenced by training and practice setting. Background: Hydroxocobalamin has been reported to interfere with the blood leak alarm on hemodialysis machines making it difficult to use this treatment modality after hydroxocobalamin infusion. Hypothesis: We hypothesized the interference with hydroxocobalamin is related to the optical properties of the medication and would trigger the blood leak alarm in the machines tested. Methods: This was a laboratory study. Hydroxocobalamin was reconstituted per package insert. Food coloring was added to 0.9 % saline to create the colors of the visual spectrum. Optical properties of absorbance and transmittance were measured. Hydroxocobalamin and the saline solutions were infused into the Fresenius 2008K™ and the Gambro Phoenix X36™ machines. Times were recorded from the start of the machine until the solution finished or the alarm triggered. Results: When evaluating the Gambro Phoenix X36™ machine and dialysis circuit, the alarm did not trigger. In contrast, the blood leak alarm on the Fresenius Introduction: Button battery ingestions represent a pediatric emergency due to the risk of esophageal impaction. When this occurs, emergent endoscopic removal is warranted, to prevent burns and perforation of the adjacent tissues. We developed a realistic model of esophageal button battery burns, in order to assess the time course of injuries caused by these objects to living tissues. Hypothesis: Button battery burns will develop when a complete electric circuit is created between the disk battery and the model of living tissue. Methods: Disk-shaped electric batteries (made of silver oxide or lithium) were placed inside slits cut into low-salt beef hot dogs. A 5-cent nickel coin was used as a control and also similarly positioned. Any changes to the inner surfaces of the hot dogs, adjacent to each metal object, were analyzed at 30, 60, 120 and 180 min, and photographic documentation made for comparisons. Results: Button batteries induced circumferential tissue damage, while the nickel coin caused no changes. The changes were voltage dependent (burns with 3-V batteries being more extensive than with 1.5-V batteries), and worsened over time for all batteries. Burns from the 3-V lithium disks were noted as early as 30 min from contact initiation. Discussion: Our hot dog model demonstrates that irreversible damage can occur within the first 30 min of button battery ingestion with some disk batteries, and provides a convincing model for the study of this pediatric injury. Future studies using liquid electrical insulators (such as oils) with this model may identify strategies to mitigate or delay the burn onset. Conclusion: A visually arresting demonstration such as ours is useful for increasing public and clinician awareness about button battery burns, and may lead to improved treatment strategies for these serious ingestion hazards.
Blood Leak Alarm
Role of Online Modules in Supplementing Emergency Medicine Residency Toxicology Education
Werner JR, Guffin JR, Dorfsman, ML University of Pittsburgh, Pittsburgh, PA, USA Background: While life-threatening toxicologic emergencies are rare, their recognition and timely intervention remain critical. Emergency medicine residents receive limited formal toxicology training. Purpose: The objective of this study was to determine if online modules are feasible education tools for teaching emergency medicine residents about toxicologic emergencies. Methods: Between August and October 2012, 46 emergency medicine residents completed an observational survey consisting of four online modules covering carbon monoxide exposure, toxic alcohol ingestion, digoxin overdose and beta-blocker overdose. Modules were authenticated by a board-certified toxicologist and designed to highlight the clinical presentation and treatment of the toxidrome. Residents completed pre and post module surveys using a five-point Likert scale. A ten-question multiple-choice test was developed to measure the residents' knowledge of the clinical presentation and treatment priorities for each of the toxidromes. This test was completed before and after the module to assess knowledge acquisition, analyzed with a paired t test. Results: Residents reported enjoying online learning before (65 %) and after the module (67 %). More residents preferred online learning (37 vs. 30 %) and thought their knowledge retention was higher when compared to classroom learning (30 vs. 17 %) after study completion. Fifty-eight percent of residents would be willing to participate in a similar module again. Overall, there was significant improvement in scores after taking the module, (56 to 72 %, p<0.01). PGY-1 residents demonstrated the largest improvement, followed by PGY-3's. (Table) Discussion: Emergency medicine residents enjoyed using online modules for continuing education of toxicology cases and would be willing to participate in a similar online module again. Conclusion: Online modules are feasible tools for use in the education of emergency medicine residents regarding toxicologic emergencies. Background: Psychoactive bath salts and synthetic cannabinoids (K2) are designer drugs that were sold as novelty products "not for human consumption" in order to bypass existing drug laws. Hospitalizations from these drugs were seen with increasing frequency in Upstate New York leading up to the July 2012 federal synthetic drug ban. Research question: Was federal legislation, enacted in July, 2012, effective in reducing bath salt and K2-related hospitalizations in Upstate New York? Methods: A retrospective review of SUNY Upstate Poison Center calls and University of Rochester Medical Center (URMC) Toxicology Consultation census comparing K2 and bath salt cases pre-and postfederal synthetic drug legislation. Results: SUNY Upstate Poison Center bath salt calls increased pre-ban from March to July with peak calls (103) occurring in July (Table 1 ). This was followed by steep decreases in August (29) and September (19) and October (3). Calls for K2 showed a similar drop from a mean of 30.3 (March-July) to 12 in August and 7 in September and October. URMC Toxicology cases averaged two consults per month for bath salts from May to July followed by no cases in the 3 months following the ban. For K2, the consult service averaged three consults per month prior to the ban with only a single consult documented in the 3 months following. Discussion: New York was among the first states to enact legislation restricting specific bath salts and synthetic cannabinoids. Despite this, ED visits and hospitalizations from these drugs were prevalent until the federal ban that added 31 specific synthetic compounds to lists of banned substances and created an analogue clause for additional synthetic chemicals was enacted in July 2012. Conclusion: Legislation restricting synthetic drugs was effective in reducing health-related consequences from abuse of bath salts and synthetic cannabinoids in Upstate New York. Background: Methoxetamine is a novel psychoactive substance that is an arylcyclohexylamine derivative of ketamine. There have been increasing reports of ketamine-related bladder toxicity, animal models have shown that ketamine can also cause kidney toxicity.
Research question: The study aims to determine the pattern of kidney toxicity associated with chronic methoxetamine exposure in a mouse model. Methods: Two-month-old Institute of Cancer Research (ICR) mice were administered 30 mg/kg/day methoxetamine intra-peritoneally (n05) or saline (n03, control) for 3 months. The animals were then sacrificed and histological examination of the kidneys was undertaken. Glomerular damage was assessed by calculating the percentage of glomeruli in randomly selected 25-μm 2 areas that showed atresia, shrinkage, or increase in cellularity. Proximal tubular cell damage was assessed by calculating the percentage of total tubular cells in randomly selected areas of 15 μm 2 each that were dying, lytic, or degenerating. The study was approved by the Animal Experimentation Ethics Committee of the Chinese University of Hong Kong.
Results:
The kidneys of all methoxetamine-treated animals showed inflammatory cell infiltration, tubular necrosis, degeneration / shrinkage of glomeruli and tubular colloidal casts. There was a greater proportion of abnormal glomeruli in methoxetamine-treated animals (23.50±14.28 %) than in control animals (10.17±13.08 %), p<0.001. Similarly, there was a greater proportion of proximal tubular cell degeneration in methoxetamine-treated animals (20.36±5.57 %) than in control animals (2.90±1.30 %), p<0.001.
Conclusions:
We have shown in this study that 3 months of methoxetamine exposure is associated with significant kidney damage both at a glomerular and tubular level. Previous work has suggested that methoxetamine is also associated with bladder toxicity, similar to that seen with ketamine. Animal models such as this are important to determine the potential pattern of chronic toxicity associated with novel psychoactive substances to ensure that clinicians can provide evidence based education to drug users. Background: Acute elemental mercury (Hg) poisoning and acrodynia are often described as distinct presentations associated with Hg exposure. Acute elemental Hg poisoning presents typically with pneumonitis while acrodynia presents with pink, often desquamating, palms and soles without fever. Research question: High fever and diffuse rash can be the initial presentation of acute Hg poisoning. Methods: Two siblings (14-year-old male and 9-year-old female) presented to the ED with fever and rash. They were discharged home with viral syndrome. The next day, they returned to the same ED with persistent fever and rash and were admitted. A third sibling (11-year-old female) developed similar symptoms and was admitted. All three children had diffuse confluent maculopapular pruritic rashes sparing the palms and soles. Other symptoms exhibited by one or more of the three siblings: high fever (107.2°F), headache, petechiae, conjunctivitis, dry cough, pharyngitis, and diarrhea. On the second ED visit, the 14 year old brought a bottle containing 300 g of 99.9 % elemental Hg that the three siblings had been playing with over the last 10 days. Environmental testing for Hg was performed at the house, blood (b) and urine (U) testing Hg testing was performed on all three siblings. Results: Home Hg vapor levels were 50 mcg/m Discussion: Although acute exposure to elemental Hg is often manifested by pulmonary injury and acrodynia, our cases demonstrate that acute elemental Hg exposure can present with a diffuse rash that spares the palms and soles, and fever. Conclusion: In the appropriate setting, rash and fever can be clinical features of elemental Hg toxicity.
Acute Elemental Mercury Poisoning Masquerading as Fever and Rash
Young
The Fall of OxyContin
® and the Rise of Opana ® : Use of Google Trends to Monitor Drug Diversion Behaviors Zuckerman MD, Neavyn MD, Boyer EW, Babu KM University of Massachusetts, Worcester, MA, USA Background: Prior research documents the use of web traffic surveillance to identify drug diversion and diversion techniques. More than 80 % of web searches are initiated via Google and are subsequently available via Google trends, a tool that has been used to monitor behaviors related to flu-like illnesses and economic indicators. Hypothesis: Internet searches related to drug diversion may shift as attitudes and behaviors change following the introduction of novel anti-diversion drug formulations. Methods: This is a retrospective analysis of a publicly available web database (Google Trends) that identifies the number of times a search term is entered relative to the total search volume across geographic regions and time. Investigators identified search terms associated with diversion of oxycodone (OxyContin® and Percocet) and oxymorphone (Opana) then correlated results with the announcement and release of new, diversion-resistant formulations. Results: Searches related to intravenous injection of OxyContin® peaked during September 2010, following the August release of a diversion-resistant reformulation, then dropped precipitously to 18 % of their peak level. In the same month, searches related to intravenous injection of Opana rose, and continued to increase as the number of OxyContin® searches fell. During the same period, searches for intravenous injection of Percocet remained steady, at around a third of peak search volume. Discussion: The surge in searches related to intravenous OxyContin® use is likely related to renewed interest in novel techniques for nonmedical use following the release of the abuse-deterrent reformulation. The precipitous drop in searches following this, along with the rise in searches related to intravenous abuse of opana, reflects shifting patterns of diversion and abuse. Of note, the relatively stable search popularity related to intravenous Percocet abuse during a period without reformulation provides an internal control. Conclusion: Continued use of Google Trends to monitor web searches related to drug diversion may predict diversion behaviors.
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which 11 % was xylazine only and 57 % was in combination with heroin. Moreover the results obtained from the analysis of the postmortem samples show that xylazine can be detected in three different matrices, blood, urine, and vitreous humor as parent drug. The higher concentration of xylazine in blood was 1.16 and 2.0 μg in urine and vitreous humor. Discussion: Xylazine as drug of abuse was detected and related to fatal intoxication cases. Conclusion: Our data indicates that xylazine is sold as drug of abuse to the addict's population of Puerto Rico. The potential harmful effect of xylazine in humans needs to be studied.
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